Back to search results

Observational Study of Magnetocardiography in Cardiac Amyloidosis

This observational study is looking at how well a non-invasive device called SandboxAQ CardiAQ Magnetocardiography (MCG) can help diagnose and track the progress of amyloidosis, a condition where abnormal proteins build up in organs. MCG is a radiation-free imaging technique that measures the heart's electrical activity. Researchers will compare MCG to other methods, like electrocardiograms (ECG). You may be able to join if you are 18 or older, can follow study requirements, and are not pregnant or breastfeeding. You also cannot have active atrial fibrillation or certain metal implants in your chest. The study aims to enroll 500 participants. We don't know the current recruitment status.

Study design
This is an observational study aiming to enroll 500 participants. It is not specified if it is randomized or blinded.
What's involved
You would have measurements taken at baseline, 6 months, 12 months, and 18 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 18 months after baseline measurements.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07218705

A Study Of MCG In Cardiac Amyloidosis

Recruiting
Not specifiedAges 18+Observational
Mayo Clinic
~500 participants
Updated 2025-12-22 on ClinicalTrials.gov
What's tested:SandboxAQ CardiAQ Magnetocardiography

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Receiver Operating Characteristic (ROC) curve
Measured over Baseline, 6 Months, 12 Months, 18 Months
+2 more outcomes measured

Conditions

Amyloidosis

Explore related trials

Amyloidosis

Where it's being run

1 sites across 1 states
Minnesota1

Study leadership

  • Mohamad Alkhouli, M.D., M.B.A. · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

Andy Dang
[email protected]
507-255-7752
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • Receiver Operating Characteristic (ROC) curveBaseline, 6 Months, 12 Months, 18 Months

    Receiver Operating Characteristic (ROC) curve is used to compare true positive rate vs false positive rate. This will be used to determine the sensitivity, specificity, and overall effectiveness of MCG.

  • Area Under the Curve (AUC) MagnetocardiographyBaseline, 6 Months, 12 Months, 18 Months

    Area Under the Curve (AUC) will be measured by mg\*h/L.

  • Area Under the Curve (AUC) ElectrocardiogramBaseline, 6 Months, 12 Months, 18 Months

    Area Under the Curve (AUC) will be measured by mg\*h/L.